{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T02:11:14Z","timestamp":1791598274536,"version":"4.3.4"},"reference-count":149,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T00:00:00Z","timestamp":1756944000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Type 2 diabetes mellitus (T2DM) and its associated complications pose a global health threat. Notably, the rise in diabetes-induced cognitive dysfunction has garnered widespread attention. T2DM patients frequently face an elevated risk of both cognitive impairment and diabetic kidney disease (DKD) comorbidity. There is evidence to suggest that kidney and brain dysfunction share common pathogenic factors, such as vascular endothelial injury, oxidative stress, and inflammation activation. Whereas, the underlying mechanisms of kidney-brain interaction and effective treatments for DKD-related cognitive decline remain incompletely understood. Our review preliminarily summarized the relationship between renal dysfunction and cognitive decline based on the existing clinical trial evidence. The mechanisms underlying DKD-related cognitive decline which mainly included the accumulation of harmful metabolites, inflammation activation and endothelial dysfunction were also clarified. And the brain renin-angiotensin-aldosterone system (RAAS) may serve as a bridge connecting renal dysfunction in DKD with cognitive impairment. In addition, we further concluded that potential lifestyle interventions and pharmacological approaches, including antioxidants, RAS inhibitors, finerenone and hypoglycemic agents, such as sodium-glucose cotransporter-2 inhibitors, liraglutide and pioglitazone may exert the preservation of cognitive function. The review could offer valuable insights for therapeutic strategies of cognitive impairment associated with diabetes and DKD in future.<\/jats:p>","DOI":"10.3389\/fendo.2025.1562518","type":"journal-article","created":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T04:12:02Z","timestamp":1756959122000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Crosstalk of kidney and brain in diabetes-related cognitive impairment and therapeutic strategies"],"prefix":"10.3389","volume":"16","author":[{"given":"Chunmei","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huikai","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.2337\/dc09-0459","article-title":"Projecting the future diabetes population size and related costs for the U","volume":"32","author":"Huang","year":"2009","journal-title":"S Diabetes Care"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMe1708949","article-title":"A new chapter for diabetic kidney disease","volume":"377","author":"de Boer","year":"2017","journal-title":"N Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)30427-1","article-title":"Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"394","author":"Zhou","year":"2019","journal-title":"Lancet"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.2337\/db12-1644","article-title":"Utrecht Vascular Cognitive Impairment Study Group. Disruption of the cerebral white matter network is related to slowing of information processing speed in patients with type 2 diabetes","volume":"62","author":"Reijmer","year":"2013","journal-title":"Diabetes"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.2337\/db16-0128","article-title":"Functional brain networks are altered in type 2 diabetes and prediabetes: signs for compensation of cognitive decrements? The maastricht study","volume":"65","author":"van Bussel","year":"2016","journal-title":"Diabetes"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-2012-111433","article-title":"Type 2 diabetes and cognitive impairment: linking mechanisms","author":"Luchsinger","year":"2012","journal-title":"J Alzheimers Dis"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2011.05.027","article-title":"Albuminuria, kidney function, and the incidence of cognitive impairment among adults in the United States","volume":"58","author":"Kurella Tamura","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2010.502","article-title":"Albuminuria and decline in cognitive function: The ONTARGET\/TRANSCEND studies","volume":"171","author":"Barzilay","year":"2011","journal-title":"Arch Intern Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.05530610","article-title":"Association of cognitive function with albuminuria and eGFR in the general population","volume":"6","author":"Joosten","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.05330611","article-title":"Kidney dysfunction and cognitive decline in women","volume":"7","author":"Sajjad","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2008.08.022","article-title":"Albuminuria, cognitive functioning, and white matter hyperintensities in homebound elders","volume":"53","author":"Weiner","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(20)30118-2","article-title":"Type 2 diabetes and cognitive dysfunction-towards effective management of both comorbidities","volume":"8","author":"Srikanth","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e3013","DOI":"10.1002\/dmrr.3013","article-title":"The impact of cognitive impairment in dementia on self-care domains in diabetes: A systematic search and narrative review","volume":"34","author":"Santos","year":"2018","journal-title":"Diabetes Metab Res Rev"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1152\/japplphysiol.90549.2008","article-title":"Effects of central arterial aging on the structure and function of the peripheral vasculature: implications for end-organ damage","volume":"105","author":"Mitchell","year":"2008","journal-title":"J Appl Physiol (1985)"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000168052.00426.65","article-title":"Relationship between aortic stiffening and microvascular disease in brain and kidney: cause and logic of therapy","volume":"46","author":"O\u2019Rourke","year":"2005","journal-title":"Hypertension"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/hr.2008.27","article-title":"Strain vessel hypothesis: a viewpoint for linkage of albuminuria and cerebro-cardiovascular risk","volume":"32","author":"Ito","year":"2009","journal-title":"Hypertens Res"},{"key":"B17","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/s0301-0082(00)00068-x","article-title":"Cerebral microvascular pathology in aging and Alzheimer\u2019s disease","volume":"64","author":"Farkas","year":"2001","journal-title":"Prog Neurobiol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2017-01922","article-title":"Diabetic microvascular disease: an endocrine society scientific statement","volume":"102","author":"Barrett","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-019-06164-1","article-title":"Deteriorated functional and structural brain networks and normally appearing functional-structural coupling in diabetic kidney disease: a graph theory-based magnetic resonance imaging study","volume":"29","author":"Wang","year":"2019","journal-title":"Eur Radiol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.2174\/092986710790827816","article-title":"Transporters in the brain endothelial barrier","volume":"17","author":"Ueno","year":"2010","journal-title":"Curr Med Chem"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000058480.77236.B3","article-title":"Is breakdown of the blood-brain barrier responsible for lacunar stroke, leukoaraiosis, and dementia","volume":"34","author":"Wardlaw","year":"2003","journal-title":"Stroke"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1159\/000314656","article-title":"The role of tubulointerstitial inflammation in the progression of chronic renal failure","volume":"116","author":"Rodr\u00edguez-Iturbe","year":"2010","journal-title":"Nephron Clin Pract"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/63.9.991","article-title":"Arterial stiffness and cognition in elderly persons with impaired glucose tolerance and microalbuminuria","volume":"63","author":"Abbatecola","year":"2008","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/glu080","article-title":"Aging exacerbates obesity-induced cerebromicrovascular rarefaction, neurovascular uncoupling, and cognitive decline in mice","volume":"69","author":"Tucsek","year":"2014","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000009642","article-title":"Genetic overlap and causal inferences between kidney function and cerebrovascular disease","volume":"94","author":"Marini","year":"2020","journal-title":"Neurology"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1159\/000357113","article-title":"Cardiorenal metabolic syndrome and diabetic cognopathy","volume":"3","author":"Hayden","year":"2013","journal-title":"Cardiorenal Med"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/s1357-2725(02)00306-0","article-title":"The brain renin-angiotensin system: location and physiological roles","volume":"35","author":"McKinley","year":"2003","journal-title":"Int J Biochem Cell Biol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.pneurobio.2011.07.001","article-title":"Brain renin-angiotensin\u2013a new look at an old system","volume":"95","author":"Wright","year":"2011","journal-title":"Prog Neurobiol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/s00424-012-1102-2","article-title":"The brain renin-angiotensin system: a diversity of functions and implications for CNS diseases","volume":"465","author":"Wright","year":"2013","journal-title":"Pflugers Arch"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-2012-111376","article-title":"The renin-angiotensin system and antihypertensive drugs in Alzheimer\u2019s disease: current standing of the angiotensin hypothesis","author":"Kehoe","year":"2012","journal-title":"J Alzheimers Dis"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/184321","article-title":"International burden of chronic kidney disease and secondary hyperparathyroidism: a systematic review of the literature and available data","volume":"2015","author":"Hedgeman","year":"2015","journal-title":"Int J Nephrol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-8-117","article-title":"Prevalence of chronic kidney disease in population-based studies: systematic review","volume":"8","author":"Zhang","year":"2008","journal-title":"BMC Public Health"},{"key":"B33","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.amjcard.2008.02.095","article-title":"Chronic kidney disease as a predictor of cardiovascular disease (from the Framingham Heart Study)","volume":"102","author":"Parikh","year":"2008","journal-title":"Am J Cardiol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.11601112","article-title":"Systematic review of structural and functional neuroimaging findings in children and adults with CKD","volume":"8","author":"Moodalbail","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2008101090","article-title":"CKD associates with cognitive decline","volume":"20","author":"Khatri","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1053\/j.ajkd.2016.01.026","article-title":"Cognitive impairment and progression of CKD","volume":"68","author":"Kurella Tamura","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfp230","article-title":"Chronic kidney disease is associated with incident cognitive impairment in the elderly: the INVADE study","volume":"24","author":"Etgen","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"B38","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s12916-016-0745-9","article-title":"Cognition in chronic kidney disease: a systematic review and meta-analysis","volume":"14","author":"Berger","year":"2016","journal-title":"BMC Med"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.14750","article-title":"Albuminuria in association with cognitive function and dementia: A systematic review and meta-analysis","volume":"65","author":"Georgakis","year":"2017","journal-title":"J Am Geriatr Soc"},{"key":"B40","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1186\/s12882-019-1425-8","article-title":"Moderately increased albuminuria, chronic kidney disease and incident dementia: the HUNT study","volume":"20","author":"Gabin","year":"2019","journal-title":"BMC Nephrol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2007.12.044","article-title":"Albuminuria and dementia in the elderly: a community study","volume":"52","author":"Barzilay","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwp426","article-title":"A prospective study of albuminuria and cognitive function in older adults: the Rancho Bernardo study","volume":"171","author":"Jassal","year":"2010","journal-title":"Am J Epidemiol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.2337\/dc08-0562","article-title":"Predictors of cognitive decline in older individuals with diabetes","volume":"31","author":"Bruce","year":"2008","journal-title":"Diabetes Care"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2006101165","article-title":"Moderate chronic kidney disease and cognitive function in adults 20 to 59 years of age: Third National Health and Nutrition Examination Survey (NHANES III)","volume":"18","author":"Hailpern","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1159\/000443497","article-title":"Factors associated with changes in brain atrophy during a three-year observation in elderly diabetic patients: effect of renal impairment on hippocampal atrophy","volume":"6","author":"Kawamura","year":"2016","journal-title":"Dement Geriatr Cognit Dis Extra"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1055\/s-0031-1277984","article-title":"Uremic encephalopathy and other brain disorders associated with renal failure","volume":"31","author":"Seifter","year":"2011","journal-title":"Semin Neurol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1053\/j.ajkd.2010.07.003","article-title":"Cognitive impairment and 7-year mortality in dialysis patients","volume":"56","author":"Griva","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"B48","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1053\/j.ajkd.2015.11.008","article-title":"The brain in kidney disease (BRINK) cohort study: design and baseline cognitive function","volume":"67","author":"Murray","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1159\/000338135","article-title":"Chronic kidney disease and cognitive impairment: a systematic review and meta-analysis","volume":"35","author":"Etgen","year":"2012","journal-title":"Am J Nephrol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.194.3.7862964","article-title":"Cerebral metabolite patterns in dialysis patients: evaluation with H-1 MR spectroscopy","volume":"194","author":"Geissler","year":"1995","journal-title":"Radiology"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1053\/j.ackd.2008.01.008","article-title":"Geriatric hemodialysis rehabilitation care","volume":"15","author":"Jassal","year":"2008","journal-title":"Adv Chronic Kidney Dis"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2004.10.024","article-title":"Cognitive function in dialysis patients","volume":"45","author":"Pereira","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2010.11.026","article-title":"Cognitive impairment in peritoneal dialysis patients","volume":"57","author":"Kalirao","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2012.12.002","article-title":"Cognitive impairment in dialysis patients: focus on the blood vessels","volume":"61","author":"Seliger","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"B55","doi-asserted-by":"publisher","first-page":"e0183965","DOI":"10.1371\/journal.pone.0183965","article-title":"An association of cognitive impairment with diabetes and retinopathy in end stage renal disease patients under peritoneal dialysis","volume":"12","author":"Liao","year":"2017","journal-title":"PloS One"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2015.62","article-title":"Ischemic brain injury in hemodialysis patients: which is more dangerous, hypertension or intradialytic hypotension","volume":"87","author":"McIntyre","year":"2015","journal-title":"Kidney Int"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1111\/sdi.12153","article-title":"What are the causes of the ill effects of chronic hemodialysis? Balancing risks: blood pressure targets, intradialytic hypotension, and ischemic brain injury","volume":"27","author":"Davenport","year":"2014","journal-title":"Semin Dial"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-139X.2010.00782.x","article-title":"Recurrent circulatory stress: the dark side of dialysis","volume":"23","author":"McIntyre","year":"2010","journal-title":"Semin Dial"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-139X.2012.01057.x","article-title":"Are there neurological consequences of recurrent intradialytic hypotension","volume":"25","author":"Eldehni","year":"2012","journal-title":"Semin Dial"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2018050462","article-title":"Investigating the relationship between cerebral blood flow and cognitive function in hemodialysis patients","volume":"30","author":"Findlay","year":"2019","journal-title":"J Am Soc Nephrol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1097\/MED.0000000000000294","article-title":"FGF-23 and cardiovascular disease: review of literature","volume":"23","author":"Batra","year":"2016","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"B62","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/hdi.12100","article-title":"FGF-23 and cognitive performance in hemodialysis patients","volume":"18","author":"Drew","year":"2014","journal-title":"Hemodial Int"},{"key":"B63","article-title":"Cognitive function and regular dialysis treatment","volume":"19","author":"Gilli","year":"1983","journal-title":"Clin Nephrol"},{"key":"B64","article-title":"Electrophysiological and neurobehavioral responses to therapy: the National Cooperative Dialysis Study","author":"Teschan","year":"1983","journal-title":"Kidney Int Suppl"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-008-9375-2","article-title":"Differential impairment of psychomotor efficiency and processing speed in patients with chronic kidney disease","volume":"40","author":"Jassal","year":"2008","journal-title":"Int Urol Nephrol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00370","article-title":"Indoxyl sulfate affects glial function increasing oxidative stress and neuroinflammation in chronic kidney disease: interaction between astrocytes and microglia","volume":"8","author":"Adesso","year":"2017","journal-title":"Front Pharmacol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1038\/nrn3114","article-title":"Neurovascular pathways to neurodegeneration in Alzheimer\u2019s disease and other disorders","volume":"12","author":"Zlokovic","year":"2011","journal-title":"Nat Rev Neurosci"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.113.01063","article-title":"Hypertension: a harbinger of stroke and dementia","volume":"62","author":"Faraco","year":"2013","journal-title":"Hypertension"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e3282f50066","article-title":"Albuminuria, but not estimated glomerular filtration rate, is associated with maladaptive arterial remodeling: the Hoorn Study","volume":"26","author":"Hermans","year":"2008","journal-title":"J Hypertens"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2011.58","article-title":"The glomerular endothelial cell coat is essential for glomerular filtration","volume":"79","author":"Frid\u00e9n","year":"2011","journal-title":"Kidney Int"},{"key":"B71","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1007\/s00395-010-0118-z","article-title":"Endothelial glycocalyx and coronary vascular permeability: the fringe benefit","volume":"105","author":"Becker","year":"2010","journal-title":"Basic Res Cardiol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.2337\/dc11-0958","article-title":"Serum level of endogenous secretory receptor for advanced glycation end products and other factors in type 2 diabetic patients with mild cognitive impairment","volume":"34","author":"Chen","year":"2011","journal-title":"Diabetes Care"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1038\/srep20692","article-title":"Albuminuria, cerebrovascular disease and cortical atrophy: among cognitively normal elderly individuals","volume":"6","author":"Cho","year":"2016","journal-title":"Sci Rep"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10112364","article-title":"Diabetes, albuminuria and the kidney-brain axis","volume":"10","author":"Ariton","year":"2021","journal-title":"J Clin Med"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/j.maturitas.2012.01.008","article-title":"The association of chronic kidney disease with brain lesions on MRI or CT: a systematic review","volume":"71","author":"Vogels","year":"2012","journal-title":"Maturitas"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.107.493593","article-title":"Chronic kidney disease is associated with white matter hyperintensity volume: the Northern Manhattan Study (NOMAS)","volume":"38","author":"Khatri","year":"2007","journal-title":"Stroke"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2012050536","article-title":"Cognitive disorders and dementia in CKD: the neglected kidney-brain axis","volume":"24","author":"Bugnicourt","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1177\/2048004016677687","article-title":"Neurological complications in chronic kidney disease","volume":"5","author":"Arnold","year":"2016","journal-title":"JRSM Cardiovasc Dis"},{"key":"B79","doi-asserted-by":"publisher","first-page":"e14566","DOI":"10.1111\/dme.14566","article-title":"Frailty is associated with a higher risk of developing delirium and cognitive impairment among patients with diabetic kidney disease: A longitudinal population-based cohort study","volume":"38","author":"Lee","year":"2021","journal-title":"Diabetes Med"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2007.02540.x","article-title":"The uremic solute indoxyl sulfate induces oxidative stress in endothelial cells","volume":"5","author":"Dou","year":"2007","journal-title":"J Thromb Haemost"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2011.06.988","article-title":"Oxidative stress and inflammation: Implications in uremia and hemodialysis","volume":"44","author":"Libetta","year":"2011","journal-title":"Clin Biochem"},{"key":"B82","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/jcbfm.2015.68","article-title":"Blood and CSF biomarkers in brain subcortical ischemic vascular disease: Involved pathways and clinical applicability","volume":"36","author":"Vilar-Bergua","year":"2016","journal-title":"J Cereb Blood Flow Metab"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/918680","article-title":"Is there inflammatory synergy in type II diabetes mellitus and alzheimer\u2019s disease","volume":"2012","author":"Lue","year":"2012","journal-title":"Int J Alzheimers Dis"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e318248e50f","article-title":"Circulating IL-6 and CRP are associated with MRI findings in the elderly: the 3C-Dijon Study","volume":"78","author":"Satizabal","year":"2012","journal-title":"Neurology"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.03500412","article-title":"Association between albuminuria, kidney function, and inflammatory biomarker profile in CKD in CRIC","volume":"7","author":"Gupta","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"e1004212","DOI":"10.1371\/journal.pgen.1004212","article-title":"Genetic determinants influencing human serum metabolome among African Americans","volume":"10","author":"Yu","year":"2014","journal-title":"PloS Genet"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.2337\/diab.28.12.1039","article-title":"Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance","volume":"28","year":"1979","journal-title":"Diabetes"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-010-0218-0","article-title":"Encephalopathies: the emerging diabetic complications","volume":"47","author":"Sima","year":"2010","journal-title":"Acta Diabetol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2009.11.005","article-title":"Type 1 diabetes exaggerates features of Alzheimer\u2019s disease in APP transgenic mice","volume":"223","author":"Jolivalt","year":"2010","journal-title":"Exp Neurol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2010.225","article-title":"Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes","volume":"68","author":"Baker","year":"2011","journal-title":"Arch Neurol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1007\/s10522-015-9569-9","article-title":"Effects of ageing and experimental diabetes on insulin-degrading enzyme expression in male rat tissues","volume":"16","author":"Kochkina","year":"2015","journal-title":"Biogerontology"},{"key":"B92","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.neuroscience.2019.09.018","article-title":"Differential levels of hippo signaling in selected brain and peripheral tissues in streptozotocin-induced cognitive dysfunction in mice","volume":"421","author":"Yu","year":"2019","journal-title":"Neuroscience"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.2337\/dc11-1697","article-title":"Near normalization of metabolic and functional features of the central nervous system in type 1 diabetic patients with end-stage renal disease after kidney-pancreas transplantation","volume":"35","author":"Fiorina","year":"2012","journal-title":"Diabetes Care"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.7861\/clinmedicine.10-5-505","article-title":"Microvascular complications: pathophysiology and management","volume":"10","author":"Vithian","year":"2010","journal-title":"Clin Med (Lond)"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.3667-11.2011","article-title":"CX3CR1 deficiency leads to impairment of hippocampal cognitive function and synaptic plasticity","volume":"31","author":"Rogers","year":"2011","journal-title":"J Neurosci"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2014-310095","article-title":"Risk factors for predicting progression from mild cognitive impairment to Alzheimer\u2019s disease: a systematic review and meta-analysis of cohort studies","volume":"87","author":"Li","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1177\/0300060518789299","article-title":"Positive correlation between cognitive impairment and renal microangiopathy in patients with type 2 diabetic nephropathy: a multicenter retrospective study","volume":"46","author":"Li","year":"2018","journal-title":"J Int Med Res"},{"key":"B98","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1080\/00365510510013866","article-title":"Cystatin C: an emerging glomerular filtration rate marker","volume":"65","author":"Larsson","year":"2005","journal-title":"Scand J Clin Lab Invest"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1055\/s-0043-109099","article-title":"RBP4\/Lp-PLA2\/Netrin-1 signaling regulation of cognitive dysfunction in diabetic nephropathy complicated with silent cerebral infarction","volume":"125","author":"Chen","year":"2017","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.2337\/dc13-0143","article-title":"Brain atrophy in type 2 diabetes: regional distribution and influence on cognition","volume":"36","author":"Moran","year":"2013","journal-title":"Diabetes Care"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-003-1235-0","article-title":"Type 2 diabetes and atrophy of medial temporal lobe structures on brain MRI","volume":"46","author":"den Heijer","year":"2003","journal-title":"Diabetologia"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-007-0688-y","article-title":"Automated measurement of brain and white matter lesion volume in type 2 diabetes mellitus","volume":"50","author":"Jongen","year":"2007","journal-title":"Diabetologia"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-2012-120928","article-title":"Are vascular factors linked to the development of hippocampal atrophy in Alzheimer\u2019s disease","volume":"32","author":"Dhikav","year":"2012","journal-title":"J Alzheimers Dis"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(04)00681-7","article-title":"Insulin and neurodegenerative disease: shared and specific mechanisms","volume":"3","author":"Craft","year":"2004","journal-title":"Lancet Neurol"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.53.2.474","article-title":"Increased risk of type 2 diabetes in Alzheimer disease","volume":"53","author":"Janson","year":"2004","journal-title":"Diabetes"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A1829","article-title":"Progressive decrease in N-acetylaspartate\/Creatine ratio in a teenager with type 1 diabetes and repeated episodes of ketoacidosis without clinically apparent cerebral edema: Evidence for permanent brain injury","volume":"31","author":"Wootton-Gorges","year":"2010","journal-title":"AJNR Am J Neuroradiol"},{"key":"B107","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.ejphar.2007.11.080","article-title":"Hyperglycaemia as a determinant of cognitive decline in patients with type 1 diabetes","volume":"585","author":"Wessels","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-005-0023-4","article-title":"Cognitive decline and dementia in diabetes\u2013systematic overview of prospective observational studies","volume":"48","author":"Cukierman","year":"2005","journal-title":"Diabetologia"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2008.05.004","article-title":"Kidney function and cognitive impairment in US adults: the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study","volume":"52","author":"Kurella Tamura","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2020.107805","article-title":"The cross-sectional association of renal dysfunction with tests of cognition in middle-aged adults with early type 2 diabetes: The GRADE Study","volume":"35","author":"Barzilay","year":"2021","journal-title":"J Diabetes Complications"},{"key":"B111","doi-asserted-by":"publisher","first-page":"e023520","DOI":"10.1136\/bmjopen-2018-023520","article-title":"How common are neurocognitive disorders in patients with chronic kidney disease and diabetes? Results from a cross-sectional study in a community cohort of patients in North Wales, UK","volume":"8","author":"Hobson","year":"2018","journal-title":"BMJ Open"},{"key":"B112","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/ki.2013.366","article-title":"The prevalence, severity, and association with HbA1c and fibrinogen of cognitive impairment in chronic kidney disease","volume":"85","author":"Seidel","year":"2014","journal-title":"Kidney Int"},{"key":"B113","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S2213-8587(14)70148-2","article-title":"Glucose regulation, cognition, and brain MRI in type 2 diabetes: a systematic review","volume":"3","author":"Geijselaers","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B114","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s12882-017-0570-1","article-title":"Prevalence and correlates of cognitive impairment in kidney transplant recipients","volume":"18","author":"Gupta","year":"2017","journal-title":"BMC Nephrol"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2016080816","article-title":"Dementia and alzheimer\u2019s disease among older kidney transplant recipients","volume":"28","author":"McAdams-DeMarco","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"B116","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1212\/WNL.0000000000002699","article-title":"Impaired renal function is associated with brain atrophy and poststroke cognitive decline","volume":"86","author":"Auriel","year":"2016","journal-title":"Neurology"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.117.017709","article-title":"Type 2 diabetes mellitus and impaired renal function are associated with brain alterations and poststroke cognitive decline","volume":"48","author":"Ben Assayag","year":"2017","journal-title":"Stroke"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.2337\/dc11-0186","article-title":"Biomarkers of renal function and cognitive impairment in patients with diabetes","volume":"34","author":"Murray","year":"2011","journal-title":"Diabetes Care"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1159\/000351424","article-title":"Association of chronic kidney disease and cerebral small vessel disease with cognitive impairment in elderly patients with type 2 diabetes","volume":"3","author":"Umemura","year":"2013","journal-title":"Dement Geriatr Cognit Dis Extra"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1185\/03007990802061818","article-title":"The role of microalbuminuria and insulin resistance as significant risk factors for white matter lesions in Japanese type 2 diabetic patients","volume":"24","author":"Anan","year":"2008","journal-title":"Curr Med Res Opin"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.2337\/dc14-1231","article-title":"Cerebral structural changes in diabetic kidney disease: African American-Diabetes Heart Study MIND","volume":"38","author":"Sink","year":"2015","journal-title":"Diabetes Care"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfv030","article-title":"Structural and functional assessment of the brain in European Americans with mild-to-moderate kidney disease: Diabetes Heart Study-MIND","volume":"30","author":"Murea","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"B123","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s11892-020-01333-9","article-title":"The contribution of kidney disease to cognitive impairment in patients with type 2 diabetes","volume":"20","author":"Ghoshal","year":"2020","journal-title":"Curr Diabetes Rep"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1016\/s0197-4580(01)00252-4","article-title":"Gene dose effect of the APOE-epsilon4 allele on plasma HDL cholesterol level in patients with Alzheimer\u2019s disease","volume":"23","author":"Hoshino","year":"2002","journal-title":"Neurobiol Aging"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2016.04.027","article-title":"APOL1 renal-risk variants associate with reduced cerebral white matter lesion volume and increased gray matter volume","volume":"90","author":"Freedman","year":"2016","journal-title":"Kidney Int"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e328301a280","article-title":"Effects of hypertension therapy based on eprosartan on systolic arterial blood pressure and cognitive function: primary results of the Observational Study on Cognitive function And Systolic Blood Pressure Reduction open-label study","volume":"26","author":"Hanon","year":"2008","journal-title":"J Hypertens"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jhh.1001964","article-title":"Effect of telmisartan\/hydrochlorothiazide vs lisinopril\/hydrochlorothiazide combination on ambulatory blood pressure and cognitive function in elderly hypertensive patients","volume":"20","author":"Fogari","year":"2006","journal-title":"J Hum Hypertens"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.3390\/ph13110379","article-title":"Perspective of SGLT2 inhibition in treatment of conditions connected to neuronal loss: focus on alzheimer\u2019s disease and ischemia-related brain injury","volume":"13","author":"Wici\u0144ski","year":"2020","journal-title":"Pharm (Basel)"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1002\/bab.1319","article-title":"Forxiga (dapagliflozin): Plausible role in the treatment of diabetes-associated neurological disorders","volume":"63","author":"Shaikh","year":"2016","journal-title":"Biotechnol Appl Biochem"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1016\/bs.irn.2020.03.018","article-title":"A role for sodium glucose cotransporter 2 inhibitors (SGLT2is) in the treatment of Alzheimer\u2019s disease","volume":"155","author":"Esterline","year":"2020","journal-title":"Int Rev Neurobiol"},{"key":"B131","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.1056\/NEJMc1713042","article-title":"Liraglutide and renal outcomes in type 2 diabetes","volume":"377","author":"Imprialos","year":"2017","journal-title":"N Engl J Med"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1177\/1533317517722005","article-title":"DPP4 inhibitors can be a drug of choice for type 3 diabetes: A mini review","volume":"32","author":"Chalichem","year":"2017","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"B133","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1001\/archneurol.2011.233","article-title":"Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial","volume":"69","author":"Craft","year":"2012","journal-title":"Arch Neurol"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1038\/sj.tpj.6500369","article-title":"Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer\u2019s disease","volume":"6","author":"Risner","year":"2006","journal-title":"Pharmacogenom J"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-017-4499-5","article-title":"Lower risk of dementia with pioglitazone, compared with other second-line treatments, in metformin-based dual therapy: a population-based longitudinal study","volume":"61","author":"Lu","year":"2018","journal-title":"Diabetologia"},{"key":"B136","doi-asserted-by":"publisher","first-page":"492","DOI":"10.2174\/187152709789824651","article-title":"Mitochondria as a therapeutic target in Alzheimer\u2019s disease and diabetes","volume":"8","author":"Moreira","year":"2009","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.29.02.06.dc05-1626","article-title":"Improving metabolic control leads to better working memory in adults with type 2 diabetes","volume":"29","author":"Ryan","year":"2006","journal-title":"Diabetes Care"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000224760.22802.e8","article-title":"Postprandial plasma glucose excursions and cognitive functioning in aged type 2 diabetics","volume":"67","author":"Abbatecola","year":"2006","journal-title":"Neurology"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-124-4-199602150-00001","article-title":"Effects of intensive diabetes therapy on neuropsychological function in adults in the Diabetes Control and Complications Trial","volume":"124","year":"1996","journal-title":"Ann Intern Med"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-171119","article-title":"The coming of age of the angiotensin hypothesis in alzheimer\u2019s disease: progress toward disease prevention and treatment","volume":"62","author":"Kehoe","year":"2018","journal-title":"J Alzheimers Dis"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2009.175","article-title":"Angiotensin-converting enzyme inhibitors and cognitive decline in older adults with hypertension: results from the Cardiovascular Health Study","volume":"169","author":"Sink","year":"2009","journal-title":"Arch Intern Med"},{"key":"B142","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1056\/NEJM199807093390202","article-title":"Reversal of lesions of diabetic nephropathy after pancreas transplantation","volume":"339","author":"Fioretto","year":"1998","journal-title":"N Engl J Med"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2007.02.043","article-title":"Characterization of brainstem preproglucagon projections to the paraventricular and dorsomedial hypothalamic nuclei","volume":"1149","author":"Vrang","year":"2007","journal-title":"Brain Res"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-9-276","article-title":"GLP-1 secretion by microglial cells and decreased CNS expression in obesity","volume":"9","author":"Kappe","year":"2012","journal-title":"J Neuroinflamm"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2025845","article-title":"Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes","volume":"383","author":"Bakris","year":"2020","journal-title":"N Engl J Med"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2110956","article-title":"Cardiovascular events with finerenone in kidney disease and type 2 diabetes","volume":"385","author":"Pitt","year":"2021","journal-title":"N Engl J Med"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab777","article-title":"Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis","volume":"43","author":"Agarwal","year":"2022","journal-title":"Eur Heart J"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.01131","article-title":"Finerenone attenuates endothelial dysfunction and albuminuria in a chronic kidney disease model by a reduction in oxidative stress","volume":"9","author":"Gonz\u00e1lez-Bl\u00e1zquez","year":"2018","journal-title":"Front Pharmacol"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115661","article-title":"Finerenone protects against progression of kidney and cardiovascular damage in a model of type 1 diabetes through modulation of proinflammatory and osteogenic factors","volume":"168","author":"Sanz-G\u00f3mez","year":"2023","journal-title":"BioMed Pharmacother"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1562518\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T04:12:04Z","timestamp":1756959124000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1562518\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,4]]},"references-count":149,"alternative-id":["10.3389\/fendo.2025.1562518"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1562518","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,4]]},"article-number":"1562518"}}